IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA: The Malaysian experience - Softcover
Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients.
"synopsis" may belong to another edition of this title.
About the Author:
I am a senior lecturer and clinical haematologist in University of Malaya, Malaysia. I am also involved in clinical research. My special interest is in chronic myeloid leukaemia.
"About this title" may belong to another edition of this title.
- PublisherLAP LAMBERT Academic Publishing
- Publication date2010
- ISBN 10 3838355830
- ISBN 13 9783838355832
- BindingPaperback
- Number of pages68
Buy New
Learn more about this copy
US$ 50.69
Shipping:
US$ 3.99
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA: The Malaysian experience
Published by
LAP LAMBERT Academic Publishing
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Apr0316110082973
Buy New
US$ 50.69
Convert currency
Stock Image
Imatinib Mesylate in the Treatment of Chronic Myeloid Leukaemia
Published by
LAP Lambert Academic Publishing
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783838355832_lsuk
Buy New
US$ 56.01
Convert currency
Stock Image
Imatinib Mesylate in the Treatment of Chronic Myeloid Leukaemia
Published by
LAP Lambert Academic Publishing 2010-07
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
PF
Quantity: 10
Seller:
Rating
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783838355832
Buy New
US$ 51.65
Convert currency
Stock Image
IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA The Malaysian experience
Published by
LAP LAMBERT Academic Publishing
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783838355832
Buy New
US$ 76.06
Convert currency
Seller Image
IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA
Published by
LAP LAMBERT Academic Publishing Apr 2010
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients. 68 pp. Englisch. Seller Inventory # 9783838355832
Buy New
US$ 53.77
Convert currency
Stock Image
IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA The Malaysian experience
Published by
LAP LAMBERT Academic Publishing
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783838355832
Buy New
US$ 57.74
Convert currency
Seller Image
IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA : The Malaysian experience
Published by
LAP LAMBERT Academic Publishing
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients. Seller Inventory # 9783838355832
Buy New
US$ 53.77
Convert currency
Seller Image
IMATINIB MESYLATE IN THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA
Published by
LAP LAMBERT Academic Publishing
(2010)
ISBN 10: 3838355830
ISBN 13: 9783838355832
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Bee Ping ChongI am a senior lecturer and clinical haematologist in University of Malaya, Malaysia. I am also involved in clinical research. My special interest is in chronic myeloid leukaemia.Imatinib mesylate is a novel drug whi. Seller Inventory # 5415968
Buy New
US$ 45.04
Convert currency